Richard P. Sequeira
99 Commercial Rd
Melbourne, VIC 3004, Australia
Melbourne, VIC 3004, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The Imbalance Between Tumor Immunosurveillance and Tumor Immune Escape in Glioblastoma.
Journal: Immunology and cell biology
Published: March 23, 2026
Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remission.
Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remission.
Journal: Journal of the neurological sciences
Published: February 05, 2026
Innate immunity and biomarkers of multiple sclerosis relapse versus remission.
Journal: Autoimmunity reviews
Published: September 10, 2025
Peripheral cytokine and monocyte phenotype associations in drug-resistant epilepsy.
Journal: Scientific reports
Published: March 31, 2025
Harnessing the innate immune system for glioblastoma therapeutics.
Journal: Journal of neuroimmunology
Published: March 03, 2025
Purinergic P2X receptor 7 (P2X7R) inhibition induced cytotoxicity in glioblastoma.
Journal: PloS one
Published: January 02, 2025
CLADIN- CLADribine and INnate immune response in multiple sclerosis - A phase IV prospective study.
Journal: Clinical immunology (Orlando, Fla.)
Published: April 26, 2024
Characterisation of the expression of P2X7 receptor, cancer stem cell markers and immunological mediators in human high-grade gliomas.
Journal: BMC neuroscience
Published: March 12, 2024
P2X7 receptor antagonism by AZ10606120 significantly depletes glioblastoma cancer stem cells in vitro.
Journal: Brain research bulletin
Published: January 30, 2024
P2X7 receptor antagonism by AZ10606120 significantly reduced in vitro tumour growth in human glioblastoma.
Journal: Scientific reports
Published: December 01, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026